{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:01:21Z","timestamp":1759960881614},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.remn.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T23:24:38Z","timestamp":1445901878000},"page":"74-80","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac sympathetic innervation assessed with 123I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator"],"prefix":"10.1016","volume":"35","author":[{"given":"P.","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3.","family":"Fabregat-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cozar-Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"S\u00e1nchez-Jurado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Estornell-Erill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Valle-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Quesada-Dorador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pay\u00e1-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ferrer-Rebolleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ridocci-Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2015.08.002_bib0175","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0735-1097(97)00361-6","article-title":"Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?","volume":"30","author":"Uretsky","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0180","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.remn.2015.08.002_bib0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0190","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0195","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigatos. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0205","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1460-9592.2003.t01-1-00219.x","article-title":"Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID","volume":"26","author":"Gradaus","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0210","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2004.08.054","article-title":"Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials","volume":"44","author":"Nanthakumar","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe048351","article-title":"Prophylactic defibrillator implantation, toward an evidence-based approach","volume":"352","author":"Kadish","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0220","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0225","first-page":"4","article-title":"Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure","volume":"101","author":"Miranda","year":"2013","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0230","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0235","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0240","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","article-title":"Prognostic value of myocardial 123I-metaiodobenzyguanidina (MIBG) parameters in patients with heart failure: a systematic review","volume":"29","author":"Verbene","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.remn.2015.08.002_bib0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11897-013-0161-9","article-title":"Cardiac metaiodobenzylguanidine imaging and heart failure","volume":"10","author":"Nakata","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.remn.2015.08.002_bib0250","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcmg.2013.02.007","article-title":"A pooled analysis of multicenter cohort studies of I-123-mIBG cardiac sympathetic innervation imaging for assessment of long-term prognosis in chronic heart failure","volume":"6","author":"Nakata","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.remn.2015.08.002_bib0255","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2009.12.066","article-title":"Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients","volume":"55","author":"Boogers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0260","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/heartjnl-2012-302321","article-title":"Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention","volume":"98","author":"Marshall","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.remn.2015.08.002_bib0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2967\/jnumed.107.042564","article-title":"Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration of left ventricular function","volume":"49","author":"Nagahara","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mnc.2003.2","article-title":"I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator","volume":"10","author":"Arora","year":"2003","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0275","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"Macdonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.remn.2015.08.002_bib0280","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2337\/dc12-2147","article-title":"Impact of diabetes mellitus on cardiac sympathetic innervation in patients with heart failure","volume":"36","author":"Paolillo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.remn.2015.08.002_bib0285","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.19.10.1083","article-title":"Demonstration of regional sympathetic denervation of the heart in diabetes","volume":"19","author":"Turpeinen","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.remn.2015.08.002_bib0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCIMAGING.110.954784","article-title":"Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervartion in heart failure patients clinical perspectives","volume":"4","author":"Gerson","year":"2011","journal-title":"Circ Cariovasc Imaging"},{"key":"10.1016\/j.remn.2015.08.002_bib0295","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.recesp.2013.06.009","article-title":"Evaluation of cardiac 123I-MIBG imaging in patients with severe left ventricular dysfunction and indication for implantable cardioverter defibrillator","volume":"66","author":"Garc\u00eda-Gonz\u00e1lez","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.remn.2015.08.002_bib0300","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.remn.2015.08.002_bib0305","first-page":"S4","article-title":"Clinical practice recommendations of American Diabetes Association 2013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.remn.2015.08.002_bib0310","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00259-007-0639-3","article-title":"I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study","volume":"35","author":"Agostini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2015.08.002_bib0315","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00259-013-2461-4","article-title":"Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure","volume":"40","author":"Pellegrino","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2015.08.002_bib0320","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1253\/circj.CJ-11-0905","article-title":"Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease","volume":"76","author":"Yufu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.remn.2015.08.002_bib0325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCULATIONAHA.112.000547","article-title":"Current evidence base for use of the implantable cardioverter-defibrillator","volume":"128","author":"Hohnloser","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.remn.2015.08.002_bib0330","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2967\/jnumed.111.095786","article-title":"Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients","volume":"53","author":"Doi","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0335","first-page":"1","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population","volume":"59","author":"From","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.remn.2015.08.002_bib0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-10-39","article-title":"Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study","volume":"10","author":"Flores-Le Roux","year":"2011","journal-title":"Cardiovasc Diabetol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X15001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X15001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T03:22:09Z","timestamp":1537240929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X15001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2253654X15001146"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2015.08.002","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac sympathetic innervation assessed with 123I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}